Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma

被引：19

作者：

Gertz, Morie A. ^{[1
]}

Buadi, Francis K. ^{[2
]}

Hayman, Suzanne R. ^{[3
]}

Lacy, Martha Q. ^{[1
]}

Dispenzieri, Angela ^{[1
]}

Dingli, David ^{[1
]}

Gonsalves, Wilson I. ^{[1
]}

Kumar, Shaji ^{[1
]}

Kapoor, Prashant ^{[2
]}

Kourelis, Taxiarchis ^{[2
]}

Hogan, William J. ^{[2
]}

机构：

[1] Mayo Clin, Dept Med, Div Hematol, Rochester, MN USA

[2] Mayo Clin, Div Hematolgy, Rochester, MN USA

[3] Mayo Clin, Dept Med, Hematol Oncol Div, Rochester, MN USA

来源：

MAYO CLINIC PROCEEDINGS | 2018年 / 93卷 / 01期

关键词：

D O I：

10.1016/j.mayocp.2017.09.012

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Systems have been put in place in the Mayo Clinic Stem Cell Transplantation program to reduce day-100 all-cause mortality. Currently our mortality has been reduced to 0.3%. Patients can undergo transplant as an outpatient, with a median hospital duration of 0 days and only 25% of patients requiring a hospital stay of 5 days or greater. Outpatient transplantation is safe and reduces patient-incurred costs. (C) 2017 Mayo Foundation for Medical Education and Research

引用

页码：56 / 58

页数：3

共 50 条

[41] Second Autologous Stem Cell Transplant: An Effective Therapy for Relapsed Multiple Myeloma
Abbi, Kamal Kant Singh
Zheng, Junting
Devlin, Sean M.
Giralt, Sergio
Landau, Heather
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (03) : 468 - 472
[42] Salvage autologous stem cell transplant is an effective regimen for relapsed multiple myeloma
Gertz, Morie A.
Lacy, Martha Q.
LEUKEMIA & LYMPHOMA, 2013, 54 (10) : 2096 - 2097
[43] Safety and tolerability of lenalidomide maintenance dosing in patients with multiple myeloma post-autologous stem cell transplant
Shockley, Abigail
Davis, James A.
Gaffney, Kelly J.
Smith, Deidra
Weeda, Erin
Hashmi, Hamza
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (07) : 1613 - 1616
[44] HIGH DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT FOR MULTIPLE MYELOMA
Ali, N.
Shaikh, M. U.
Adil, S.
BONE MARROW TRANSPLANTATION, 2015, 50 : 5627 - 5627
[45] THE AMBULATORY AUTOLOGOUS STEM CELL TRANSPLANT PROGRAMME FOR MULTIPLE MYELOMA: A SERVICE EVALUATION
Brough, Ethan
BONE MARROW TRANSPLANTATION, 2024, 59 : 695 - 696
[46] Results of autologous stem cell transplant in multiple myeloma patients with renal failure
Badros, A
Barlogie, B
Siegel, E
Roberts, J
Langmaid, C
Zangari, M
Desikan, R
Shaver, MJ
Fassas, A
McConnell, S
Muwalla, F
Barri, Y
Anaissie, E
Munshi, N
Tricot, G
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (04) : 822 - 829
[47] Experience of Autologous Stem Cell Transplant in Multiple Myeloma: The Patient and Caregiver Perspective
Hansen, Doris K.
Bixby, Todd
Fixler, Karen
Shea, Lisa
Brittle, Christine
Brunisholz, Kimberly
Liu, Yi-Hsuan
Huo, Jinhai Stephen
JOURNAL OF PATIENT EXPERIENCE, 2023, 10
[48] Outcome of Patients with Multiple Myeloma by Ethnicity in the Setting of Autologous Stem Cell Transplant
Sasaki, Koji
Bashir, Qaiser
Shah, Nina
Hosing, Chitra
Popat, Uday R.
Nieto, Yago
Parmar, Simrit
Shah, Jatin
Weber, Donna
Thomas, Sheeba
Orlowski, Robert Z.
Champlin, Richard E.
Qazilbash, Muzaffar H.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S231 - S232
[49] Autologous stem cell transplant for multiple myeloma and lymphoma without transfusion support
Ford, PA
Matthews, BA
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 65 - 66
[50] Multiple myeloma and autologous stem cell transplant:: a single-centre experience
Amutio, E.
Garcia-Ruiz, J.
Olazabal, I.
Arambarri, S.
BONE MARROW TRANSPLANTATION, 2008, 41 : S442 - S442

← 1 2 3 4 5 →